Corona Remedies IPO Date: Your Complete Guide to This Pharma Powerhouse Launch

Heard the chatter about Corona Remedies IPO? With Day 2 underway on December 9, 2025, you're right to check the corona remedies IPO date, track the dipping corona remedies IPO GMP, and weigh if it's your next stock win. Think of GMP like a weather forecast for listing gains – sunny at ₹300 yesterday, cloudier at ₹240-262 now amid market jitters. This Gujarat pharma gem's OFS could still deliver if subscription heats up.​

Get the latest on corona remedies IPO date (Dec 8-10, 2025), corona remedies IPO GMP (₹240-262 today, downtrend), Day 2 subscription (2x overall). Learn from the best trading course in India for smart IPO plays.​

What is Corona Remedies? Company Snapshot

What sets Corona Remedies apart in the crowded pharma world? Started in 2004 from Ahmedabad, it specializes in women's healthcare, cardio-diabeto, pain management, urology – meds for real-life needs like period care or heart health. Boasting two plants producing 1.2B+ units yearly, 2,671 field staff in 22 states, and 71 brands (62% revenue from top segments), it's a steady operator.​

Key Stats at a Glance:

• Revenue: ₹1,202 Cr FY25 (18% YoY growth).​

• PAT: ₹149 Cr (65% jump).​

• ROE: 27.5%, debt low at 0.10x.​

Like your trusted family doctor, it focuses on reliable, recurring demand.

Corona Remedies IPO Date: Key Timeline Breakdown

The corona remedies IPO date spans December 8-10, 2025 – Day 2 today! Allotment December 11, refunds/demat December 12, BSE/NSE listing December 15. UPI cut-off: 5 PM tomorrow – don't sleep on it.​

Full Timeline Table:

It's a quick race; bid early via your broker.

Price Band and Lot Size Explained Simply

Shares at ₹1,008-₹1,062 – bid upper for cut-off edge. Retail minimum: 14 shares (₹14,868). HNIs: 196 shares (₹2.08L min), employees ₹54 discount. Low barrier means everyday investors like you can join.​

Like entry to a popular fair – affordable ticket, big fun potential.

Corona Remedies IPO GMP: Latest Day 2 Update

Corona remedies IPO GMP cooled to ₹240-₹262 today (down from ₹300), eyeing listing at ₹1,302-1,324 (~24% gain on upper band). Grey market's volatile with Nifty dips, like a seesaw on windy days. Day 1: ₹262; track via sites like IPOWatch.​

GMP Trend Today:

• Current: ₹240-262 (Mild dip, still positive).​

• Gain Potential: 22-25%.​

Not a crash, but caution – subscription will tell.

Subscription Status: Day 2 Surge Breakdown

Day 2 at 11 AM: 2x overall (86L bids vs 45.7L shares) – retail 2x+, NII 4x, QIBs just 2%. Day 1 was tepid at 62% (retail 37-87%, NII 27-79%, QIB 0%). Employees led early at 87%. Momentum building – QIBs could push it higher.​

Total OFS: 61.71L shares, ₹655 Cr.​

Financial Health: Revenue, Profits, and Growth

Solid base: FY25 revenue ₹1,202 Cr (+18%), PAT ₹149 Cr (+65%), EBITDA 20.55%. P/E 43x pre-IPO, fair for 27% ROE. 90%+ plant utilization, EU GMP nod for exports.​

Growth Drivers:

• Top Segments: 62% revenue from women's health, cardio, pain.​

• Expansion: Pan-India + global push.​

Roots deep, growth steady.

Why Invest? Strengths and Opportunities

Brand Power: 71 SKUs, chronic focus = sticky sales. Network: Deep in 22 states. Pharma boom in aging India; OFS liquidity for shareholders. GMP dip? Buying chance if sub picks up.​

Long-term hold potential post-listing.

Risks You Can't Ignore Before Applying

Watch out: Revenue Concentration (62% top therapies). Regulatory Risks: CDSCO/FDA approvals, competition. GMP downtrend signals volatility; no fresh funds via OFS. Market dips amplify losses – stomach test needed?​

How to Apply for Corona Remedies IPO Easily

Log into Zerodha/Groww, select IPO, bid lots (1-13 retail) at cut-off via UPI/ASBA. Funds blocked till allotment – safe, no interest hit. Registrar: Bigshare.​

Quick Steps:

1. Check eligibility (retail ≤₹2L).

2. UPI mandate confirm.

3. Done by 5 PM Dec 10.​

Anchor Investors: Big Names Backing It

₹195 Cr from 15 anchors (18.3L shares at ₹1,062) – MFs/FIIs locked 30/90 days. Vote of confidence amid sub pickup.​

Post-Listing Expectations and GMP Trends

Dec 15 listing; GMP hints 20-25% pop if sub >5x. Volatility watch – hold for Q4 results if chronic sales shine. Track GMP daily.​

Best Trading Course in India for IPO Success

Want edge on IPOs like this? Best trading course in India: Trading Shastra's Supreme Trader (3 months, live options/hedging, 28% sim returns). Booming Bulls for newbies, FinGrad for strategies. Master GMP reading, timing – turn buzz into bucks.​

Top 3:

• Trading Shastra: Practical mentorship.​

• Booming Bulls: Beginner ramp-up.​

• FinGrad: Nifty/IPO focus.​

Your shortcut to pro trades.

Compare Top Trading Academies Quick

Match to your level – practice wins.

IPO Tips for Beginners Like You

• Bid cut-off, max lots retail.

• Diversify across 3-5 IPOs.

• Monitor sub/GMP live.

• Pair with best trading course in India for analysis.

Future Outlook for Corona Remedies Stock

Chronic portfolio + expansion = resilient play. If sub closes strong, 20%+ listing; long-term pharma tailwinds. GMP dip temporary?​

Day 2's 2x sub revives hopes – apply or watch?

FAQs

What is the exact corona remedies IPO date?
December 8-10, 2025, with Day 2 ongoing today.​

What is the current corona remedies IPO GMP?
₹240-₹262 as of December 9, down but positive (~24% gain).​

What is the best trading course in India for IPOs?
trendy traders academy for hands-on mentorship and strategies.​

Corona Remedies IPO Day 2 subscription status?
Over 2x overall; NII 4x, retail 2x+ at 11 AM.​

When do Corona Remedies shares list on BSE/NSE?
Tentatively December 15, 2025.​